Robin Zenger Baker, - Couples Therapy in Belmont, MA

Robin Zenger Baker, is a Marriage & Family Therapist based in Belmont, Massachusetts. Robin Zenger Baker is licensed to practice in * (Not Available) (license number ) and her current practice location is 38 Carleton Cir, Belmont, Massachusetts. She can be reached at her office (for appointments etc.) via phone at (617) 629-6790.

NPI number for Robin Zenger Baker is 1558742833 and her current mailing address is 38 Carleton Cir, Belmont, Massachusetts. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1558742833.

Contact Information

Robin Zenger Baker,
38 Carleton Cir,
Belmont, MA 02478
(617) 629-6790
Not Available

Healthcare Provider's Profile

Full NameRobin Zenger Baker
GenderFemale
SpecialityMarriage & Family Therapist
Location38 Carleton Cir, Belmont, Massachusetts
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1558742833
  • Provider Enumeration Date: 06/12/2015
  • Last Update Date: 06/12/2015

Medical Identifiers

Medical identifiers for Robin Zenger Baker such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1558742833NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
106H00000XMarriage & Family Therapist (* (Not Available))Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Robin Zenger Baker is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Robin Zenger Baker,
38 Carleton Cir,
Belmont, MA 02478-2942

Ph: (617) 852-7025
Robin Zenger Baker,
38 Carleton Cir,
Belmont, MA 02478

Ph: (617) 629-6790

News Archive

Brachytherapy may benefit obese prostate cancer patients

Brachytherapy, also called seed implants, may be a more beneficial treatment than surgery or external beam radiation therapy for overweight or obese prostate cancer patients, according to a study published in the August issue of the International Journal of Radiation Oncology-Biology-Physics, the official journal of the American Society for Therapeutic Radiology and Oncology.

Twitter may be effective, untapped resource to boost patient enrollment in cancer clinical trials

Twitter may be an effective, untapped resource to stimulate interest in cancer clinical trials and boost enrollment, physicians at the Abramson Cancer Center of the University of Pennsylvania suggest in a new research letter in JAMA Oncology. Analyzing thousands of lung cancer tweets on the social media site revealed that a surprisingly large number were about clinical trials, particularly ones on immunotherapy, although none were used for recruitment.

DMC recommends Emisphere Technologies' to proceed with oral calcitonin trial for OP and OA

Emisphere Technologies, Inc. today announced that an independent Data Monitoring Committee ("DMC") informed Novartis and its partner Nordic Bioscience about their recommendation to proceed with the Osteoporosis ("OP") Phase 3 Study 2303 and the Osteoarthritis ("OA") Phase 3 Study 2301 exploring the safety and efficacy of an oral formulation of salmon calcitonin to treat patients with osteoporosis and osteoarthritis of the knee.

Study: Young adults don't know what's in the vaping products they use

Young adults don't know what's in the products they vape and often don't know what brand of vaping products they use, according to a new study by researchers at the Stanford University School of Medicine.

New England Biolabs adds OneTaq and OneTaq Hot Start DNA Polymerases to line of PCR reagents

New England Biolabs has expanded its line of PCR reagents to include OneTaq™ and OneTaq Hot Start DNA Polymerases. Optimized blends of Taq and Deep Vent® DNA Polymerases, these new products offer robust amplification across a wide range of templates, including routine, AT-rich and GC-rich amplicons.

Read more News

› Verified 7 days ago


Marriage & Family Therapist in Belmont, MA

Malgorzata Frajnt- Zielinska,
Couples Therapy
Medicare: Not Enrolled in Medicare
Practice Location: 115 Mill St, Belmont, MA 02478
Phone: 313-769-2876    
Ms. Grace M Williams, LICSW
Couples Therapy
Medicare: Accepting Medicare Assignments
Practice Location: 53 Cushing Avenue, Belmont, MA 02478
Phone: 617-584-9518    
Dr. Kyle D. Killian, PH.D., LMFT
Couples Therapy
Medicare: Not Enrolled in Medicare
Practice Location: 62 Lexington St, Belmont, MA 02478
Phone: 513-523-2409    
Sarah Morse, LMFT
Couples Therapy
Medicare: Not Enrolled in Medicare
Practice Location: 75 Grove St, Belmont, MA 02478
Phone: 978-996-7984    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.